|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||0.5598 - 0.5890|
|52 Week Range||0.4440 - 1.6000|
|Beta (3Y Monthly)||7.78|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
CORAL GABLES, FL / ACCESSWIRE / February 14, 2019 / What's incredible about the marijuana stock market is the sheer amount of excitement surrounding companies in the cannabis industry. As we've seen over the course of the past few years, more countries have brought forth legislation in favor of legalizing marijuana for recreational, as well as medicinal, purposes, and as a result, companies in the space have seen an influx in investor attention. If companies continue like this, the marijuana industry may see impressive gains as a result of favorable public opinions.
Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") is pleased to announce the appointments of Brian Schmitt as Chief Financial Officer, Jason Sonshine as Vice President, Strategy, and Carla Nawrocki as Vice President, Investor Relations of the Company. Brian Schmitt, CFO, is an accomplished finance and accounting executive with approximately 30 years of experience in both private and publicly-traded companies. Most recently, Mr. Schmitt acted as the CFO at EnerCare Inc., where during his tenure with the company he played a large part in growing the company through acquisition and helped carve out their strategy, systems integration and operating plan.
HENDERSON, NV / ACCESSWIRE / February 8, 2019 / January's bull run for the cannabis industry led to a natural correction; it looks like the sector is gaining support for its next push, there are several ...
Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") today announced the termination of the definitive agreement dated March 3, 2018 (the “Agreement”) between the Company and FV Pharma Inc., a wholly-owned subsidiary of FSD Pharma Inc. (“FSD Pharma”) (CSE:HUGE) governing the joint venture between the parties. The joint venture was formed with the intention of developing a portion of FSD Pharma's cannabis cultivation facility located in Cobourg, Ontario (the “JV Facility”) in mutually agreed staged phases (the “JV Facility Development”).
NEW YORK, NY / ACCESSWIRE / February 4, 2019 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Auxly Cannabis (CBWTF) a vertically integrated cannabis company. Auxly is creating a world-class platform by forming partnerships with best-in-class cultivators, product innovators, and developers, researchers, and marketers. Auxly is a vertically integrated cannabis company with diverse operations across Canada and Uruguay.
Why Auxly Cannabis Group Stock Grew ~6.75% on January 25Stock performanceOn January 25, on the OTC markets, Auxly Cannabis Group’s stock price closed at $0.72, which is ~6.75% higher than its close of $0.67 on January 24 and reflects ~8% growth
Auxly Cannabis Group Enters Agreement with Curative CannabisDealToday, Auxly Cannabis Group (CBWTF) announced that it entered an agreement with Curative Cannabis for the acquisition of 46% of Curative’s common shares in exchange for the issuance
Auxly Cannabis Group Inc. (XLY.V) (CBWTF) (the "Company") is pleased to announce that the Company has signed a definitive agreement (the “Transaction”) with 2368523 Ontario Limited (d/b/a) Curative Cannabis ("Curative"). The Company will acquire 46% of the common shares of Curative and enter into a long-term cannabis purchase and sale agreement to fund the construction and development costs of Curative’s cannabis cultivation facility in Chatham-Kent, Ontario (the “Facility”). The Facility is designed as a purpose-built indoor facility for the production of ultra-premium cannabis product.
According to data compiled by Brightfield Group, the U.S. CBD market is expected to reach USD 22 Billion by 2022, outpacing the rest of the cannabis market combined. Many are using CBD over other pain relievers such as ibuprofen or opioids. While these over-the-counter pain relievers may help with pain relief and reduce inflammation, they pose risks in the form of many side effects.
Auxly Cannabis Group Inc. (XLY.V) (CBWTF) (the "Company") is pleased to announce that, further to its previous releases, it has completed the acquisition of 80% of the outstanding common shares (the “Transaction”) of Inverell S.A. (“Inverell”). The Transaction positions the Company as a leader in the global CBD economy with a highly efficient, low-cost source of cannabinoids for international distribution, including through the Company's strategic partnership with ICC International Cannabis Corporation Inc. (CSE:WRLD) which provides the Company with access to 16 markets through a network of 35,000 pharmacies.
Auxly Cannabis: An Overview for Investors (Continued from Prior Part) ## Recent developments In 2018, Auxly Cannabis (CBWTF) received licensing for its Kolab and CannTx projects. The Kolab project received a license for Health Canada by Canada’s Access to Cannabis for Medical Purposes Regulations. The license for the Kolab project is a significant milestone for Auxly Cannabis’ growth. Through the Kolab project, Auxly Cannabis can sell cannabis for medical purposes and adult use across Canada. In 2018, Auxly Cannabis completed the acquisition of Inverell. The company received approval from Uruguay’s regulatory authorities. The acquisition of Inverell will help Auxly Cannabis by providing a low-cost source of cannabinoids to address the global demand. Auxly Cannabis entered into a long-term supply agreement with Delta 9 Cannabis. Auxly Cannabis made a strategic investment in the company. According to the agreement with Delta 9 Cannabis, Auxly Cannabis holds the rights to purchase 1,000 kilograms of dried cannabis starting in January 2019. The amount can be expanded to 5,000 kilograms per annum starting in July 2020. According to the agreement, Auxly Cannabis can purchase 100 kilograms of trim per annum starting in January 2019 and 500 kilograms per annum starting in July 2020. ## Cash position Auxly Cannabis’ net cash and cash equivalents grew from 33,454,000 Canadian dollars on December 31, 2017, to 236,920,000 Canadian dollars at the end of the third quarter on September 30, 2018. Auxly Cannabis’ total assets grew from 92,579,000 Canadian dollars on December 31, 2017, to 501,040,000 Canadian dollars on September 30, 2018. In the first nine months of 2018, Auxly Cannabis used around 75,307,000 Canadian dollars of cash for investing activities, which included investments in subsidiaries and its partners. Browse this series on Market Realist: * Part 1 - Auxly Cannabis: Analyzing the Stock Performance * Part 2 - Auxly Cannabis: Business Strategies and Financial Projections
Auxly Cannabis (CBWTF) holds assets in all of the segments in the cannabis industry’s value chain. The company has three important divisions—upstream, midstream, and downstream.
Auxly Cannabis: An Overview for Investors ## Stock performance On January 7, Auxly Cannabis’ (CBWTF) stock price closed at $0.67, which is ~2.95% growth from its close of $0.65 on January 4. Auxly Cannabis’ stock price has grown consistently since December 24. On December 24, Auxly Cannabis’ stock price grew ~15.74% to $0.54 from $0.46 on December 21. On December 24, the company hit its 52-week low of $0.44. Auxly Cannabis’ stock price closed at $0.67 on January 7, which is ~52% growth from its 52-week low of $0.44 on December 24. The stock hit its 52-week high of $2.7 on January 17, 2018. ## Financials in a nutshell Auxly Cannabis reported revenues of 512,000 Canadian dollars in the third quarter. The company reported net expenses of 17.1 million Canadian dollars in the third quarter—compared to 5.2 million Canadian dollars in the third quarter of 2017. Vivo Cannabis (VVCIF) generated revenues of 4.3 million Canadian dollars in the third quarter. HEXO (HYYDF) reported revenues of $5.7 million in the first quarter of fiscal 2019. Auxly Cannabis’ net comprehensive loss in the third quarter was 4.6 million Canadian dollars—compared to 5.7 million Canadian dollars in the same period the previous year. In the first nine months of 2018, Auxly Cannabis’ net revenues were 512.00 Canadian dollars. During the same period, Auxly Cannabis reported unrealized gains and fair value changes of 7.1 million Canadian dollars. The company reported net expenses of 36.8 million Canadian dollars during the first nine months of 2018—compared to 8.3 million Canadian dollars during the same period the previous year. ## Analysts’ recommendations Among the two analysts tracking Auxly Cannabis in January 2019, one recommended a “strong buy,” while one recommended a “buy.” Continue to Next Part Browse this series on Market Realist: * Part 2 - Auxly Cannabis: Business Strategies and Financial Projections * Part 3 - Auxly Cannabis: Developments and Cash Equivalents
2018 was historic for the marijuana industry and marijuna stocks in general. This excitement will continue for years, as marijuana is in the early stages of a bull market that should last a decade or longer. Canada topped the headlines when it legalized recreational use in October. In the U.S., marijuana is now legal in some form in 33 of the 50 states, plus Washington, D.C. Expect that number to increase next year. Canada's new law created enormous winners. Even with the recent selling, they are some of the best performers in the market. That's after a nation of 36.7 million people legalized marijuana. Imagine what will happen when the U.S. -- with nearly nine times that many people -- follows suit! InvestorPlace - Stock Market News, Stock Advice & Trading Tips Still, we have to expect more volatility in 2019. That's the nature of investing in early trends, especially marijuana stocks, which involve companies that are transitioning from formerly illegal products to legal. There will be more pullbacks like the one we've seen recently. There will also be rallies, like the one from mid-August to mid-September when a lot of marijuana stocks more than doubled. * 10 Oversold Stocks Due for a Bounce We want to own these companies through all of the ups and downs. As legalization spreads and long-term fundamentals improve, potential profits get bigger. Today, I'd like to share three marijuana stocks to buy that are some of the most well positioned in the market. ### Charlotte's Web (CWBHF) Source: Shutterstock Let's start this list of strong marijuana stocks to buy with my pick in InvestorPlace's Best Stocks for 2019 contest -- Charlotte's Web (OTCMKTS:CWBHF). CWBHF stock is a huge beneficiary of the passage of the 2018 Farm Bill, which legalized hemp for the first time in nearly a century. Hemp is a derivative of cannabis, but there are very important differences between it and marijuana. The biggest is the amount of tetrahydrocannabinol (THC), which is the chemical compound that gets you "high." Marijuana can contain up to 30% THC while the hemp plant has less than 0.3%. Hemp also has more cannabidiol (CBD), another chemical compound that does not have the psychoactive traits that THC does. CBD is considered one of the most beneficial compounds available to humans. It is used to make CBD oil, which has been used by wellness and medical professionals for years as an alternative to traditional pharmaceuticals to treat everything from anxiety and depression to chronic pain to inflammation to childhood epilepsy. If it were a drug, we would call it a wonder drug. Charlotte's Web is a leader in the hemp-derived CBD space, and as the market leader, it has the ability to scale quickly to meet the soon-to-be booming demand for products. You can learn more about the company and its upcoming catalysts by checking out this article. According to Brightfield Group, the hemp-CBD market will reach $591 million this year. By 2022, it will soar to $22 billion! CWBHF stands to capture a lot of that growth. With CBD now poised to go mainstream, the company's profit potential is about to increase dramatically. ### Auxly Cannabis Group (CBWTF) Source: Shutterstock Formerly known as Cannabis Wheaton, Auxly Cannabis Group (OTCMKTS:CBWTF) is the first streaming company in the marijuana industry. When I came across it in my research it immediately caught my attention as it bridges together two of my favorite investment trends -- streaming royalty payments and marijuana. Through its investments in small marijuana-related companies, CBWTF is building a diverse portfolio that touches all levels of the industry. As an investor, you are gaining instant diversification and lowering any company-specific risk associated with investing in emerging companies. Auxly is really starting to take shape as its business model begins to pay off. For example, one of its investments -- Dosecann LP, a wholly owned subsidiary of Auxly -- received approval from Health Canada as a marijuana processor in late December. After reporting very little revenue last quarter, the company is projected to end fiscal 2018 with revenue of $3.18 million. Analysts expect that number to skyrocket to $121.2 million in fiscal 2019 and grow even larger to $417.2 million in fiscal 2020. There isn't a whole lot of coverage on CBWTF, so keep in mind that futures projections are just that. However, I have been a fan of this company's business model for some time now and all it takes is a few of its investments to take off in order to see big growth in the coming years. * 10 Stocks to Pull From the Bear Market Bargain Bin This marijuana stock is small compared to its peers, but the upside potential outweighs the risk at current prices. ### ### Canopy Growth (CGC) Source: Shutterstock Canopy Growth (NYSE:CGC) is the world's largest publicly traded marijuana company, and as a result, it finds itself at the forefront of the marijuana mega-trend. With the globalization of marijuana serving as a major catalyst in 2019, this is a name we certainly want to have exposure to. This company made headlines last year when it received a $4 billion investment from Constellation Brands (NYSE:STZ), the maker of Corona beer. This increased its previous 9.9% stake in CGC to 38%. The initial investment was made in 2017 and marked the first big move by a U.S.-based alcohol company into the marijuana sector. Canopy Growth has made two important announcements recently. The first was in early December when it entered the cannabis vaporizer business through a 220 Canadian dollar acquisition of Volcano Manufacturer. And following the passing of the Farm Bill, it said that it would participate in the now-legal U.S. hemp market. This could be really big for the company given its position as the current world leader in marijuana. Over the last year, this company has continued to expand into new markets and regions of the world. This is exactly what a leader should do, and CGC has the edge over its competitors to remain at the head of the pack of marijuana stocks for years to come. Matthew McCall is the founder and president of Penn Financial Group, an investment advisory firm, as well as the editor of Investment Opportunities and Early Stage Investor. He has dedicated his career to getting investors into the world's biggest, most revolutionary trends BEFORE anyone else. The power of being "first" gave Matt's readers the chance to bank +2,438% in Stamps.com (STMP), +1,523% in Ulta Beauty (ULTA), +1,044% in Tesla (TSLA), +611% in Liquefied Natural Gas Limited (LNGLY), +324% in Bitcoin Services (BTSC), just to name a few. If you're interested in making triple-digit gains from the world's biggest investment trends BEFORE anyone else, click here to learn more about Matt McCall and his investments strategy today. ### More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Stocks to Buy Down 20% in December * 5 Chinese Stocks to Avoid Now (But Buy Later) * 3 Big Gainers That Easily Could Be the Best Stocks to Buy Compare Brokers The post The 3 Strongest Marijuana Stocks to Buck Short-Term Paralysis appeared first on InvestorPlace.
Pot stock investors have a number of extra challenges to navigate when analyzing cannabis industry earnings reports.
Auxly Cannabis Group Inc. (XLY.V) (CBWTF) ("Auxly" or the "Company") is pleased to announce the appointment of Genevieve Young and Jean-Paul Gaillard as independent members of its board of directors, effective immediately. Following the appointments, Auxly’s board will consist of five members, three of whom are independent from the Company. Genevieve Young is the President and Chief Operating Officer of Global Public Affairs, Canada’s leading privately held strategic communications and government advocacy consultancy representing some of Canada’s largest and most dynamic organizations.
CORAL GABLES, FL / ACCESSWIRE / December 27, 2018 / The legislative battle to federally legalize marijuana has occupied media headlines over the course of the last year, but more recently the conversation has shifted to how the market will respond following Congress' passing of the farm bill which will allow $867 million to go the agricultural industry as a result of the legalization of hemp. American Premium Water Corporation (HIPH), Charlotte's Web Holdings Inc (CWBHF), Aphria, Inc (APHA) (APHA), and Auxly Cannabis Group Inc (CBWTF) are 4 pot stocks picking up speed just before the new year. American Premium Water Corporation (HIPH) is a company you may not have heardof, but could benefit from taking a look at.
Auxly Cannabis (CBWTF) is expected to report revenues of 4.34 million Canadian dollars in fiscal 2018. Analysts expect the company to report revenues of 165.33 million Canadian dollars in fiscal 2019, which is a YoY (year-over-year) rise of 3,709.49%. The company is also expected to report revenues of 569.38 million Canadian dollars in fiscal 2020, which is a YoY rise of 244.39%.
Auxly Cannabis (CBWTF) is focused on expanding its presence and increasing its cultivation capacity across major international markets in South America, Africa, and Europe. On April 10, Auxly Cannabis acquired an 80% stake in the common shares of Inverell S.A. for a consideration of $15.0 million. According to Auxly Cannabis’ corporate presentation, Inverell S.A. is a licensed cannabis operator with three cultivation licenses for outdoor hemp production in Uruguay.
According to Auxly Cannabis’ corporate presentation, the company is expected to have a domestic production capacity of 1,000 kilograms, all produced in Canada, by the end of fiscal 2018. The company is expected to ramp-up to a production capacity of 50,000 kilograms by end of fiscal 2019—40,000 kilograms will be from Canada, while 10,000 kilograms will be from international markets. Auxly Cannabis (CBWTF) is expected to have a domestic production capacity of 130,000 kilograms and an international production capacity of 10,000 kilograms by end of fiscal 2020.
In the third-quarter earnings press release, Auxly Cannabis (CBWTF) announced that it completed the design of the third phase of the cultivation facility by a wholly-owned subsidiary, Kolab Project, in Carleton Place, Ontario. According to Auxly Cannabis’ corporate presentation, the first phase of the cultivation facility in Ontario is estimated to be 10,000 square feet. According to the company’s corporate presentation, the second phase of the cultivation facility at Ontario is estimated to be 10,000–18,000 square feet.